EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,230 | -18.9% | 5,468 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $106,298 | -31.5% | 5,468 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $155,127 | -2.9% | 5,468 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $159,830 | +10.6% | 5,468 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $144,465 | -40.5% | 5,468 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $242,943 | -36.8% | 5,468 | -29.6% | 0.00% | -33.3% |
| Q1 2022 | $384,290 | +51.3% | 7,765 | +55.7% | 0.00% | +50.0% |
| Q4 2021 | $253,989 | -8.7% | 4,988 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $278,231 | +30.3% | 4,988 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $213,486 | +2.5% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $208,199 | -10.4% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $232,291 | +9.6% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $211,890 | -11.5% | 4,988 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $239,324 | +4.3% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $229,448 | -23.4% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $299,679 | +6.2% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $282,171 | +1.6% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $277,732 | +10.3% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $251,844 | +25.3% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $200,967 | -41.9% | 4,988 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $345,818 | -8.3% | 4,988 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $377,000 | +75.3% | 4,988 | +22.5% | 0.00% | +33.3% |
| Q1 2018 | $215,000 | -1.4% | 4,073 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $218,000 | – | 4,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |